Immunohistochemical analysis reveals that sections from the dietary FKA–treated prostate cancer CSC xenograft tumors exhibited a significant reduction in the number of Ki67-positive cells by more than 64% compared to those from the vehicle control diet group (Figure 4B, **: P < 0.01). The gene discussed is MKI67; the disease is prostate carcinoma.